{"id":1227,"date":"2020-04-08T10:31:16","date_gmt":"2020-04-08T08:31:16","guid":{"rendered":"http:\/\/invivo.partners\/?post_type=portoflio_invivo&#038;p=1227"},"modified":"2021-09-02T16:14:50","modified_gmt":"2021-09-02T14:14:50","slug":"pulmobiotics","status":"publish","type":"portoflio_invivo","link":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/pulmobiotics\/","title":{"rendered":"Pulmobiotics"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Pulmobiotics \u00e9s una empresa <em>spin-off<\/em> de el <strong>Centre de Regulaci\u00f3 Gen\u00f2mica<\/strong> (CRG). \u00c9s una empresa de ci\u00e8ncies de la vida en fase precl\u00ednica que utilitza la biologia sint\u00e8tica per desenvolupar una nova <strong>plataforma bioterap\u00e9utica <\/strong>per tractar malalties pulmonars humanes. La <strong>plataforma<\/strong> es basa en bacteris pulmonars atenuats capa\u00e7os d&#8217;administrar agents terap\u00e8utics en el pulm\u00f3 amb diferents activitats, &nbsp;per exemple, antimicrobianes, de regeneraci\u00f3 de teixits i de modulaci\u00f3 del sistema immunitari.<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>CEO: Claudio Santos<\/li><li>CSO i cofundadora: Dra. Maria Lluch<\/li><li>Assessor i Cofundador: Prof. Luis Serrano<\/li><li>Ubicaci\u00f3: Barcelona<\/li><li>P\u00e0gina web: <strong><a rel=\"noreferrer noopener\" href=\"https:\/\/www.pulmobio.com\/\" target=\"_blank\">pulmobio.com<\/a><\/strong><\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"featured_media":0,"template":"","tipo_portfolio":[507],"class_list":["post-1227","portoflio_invivo","type-portoflio_invivo","status-publish","hentry","tipo_portfolio-invivoventures"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pulmobiotics - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/pulmobiotics\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pulmobiotics - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"Pulmobiotics \u00e9s una empresa spin-off de el Centre de Regulaci\u00f3 Gen\u00f2mica (CRG). \u00c9s una empresa de ci\u00e8ncies de la vida en fase precl\u00ednica que utilitza la biologia sint\u00e8tica per desenvolupar una nova plataforma bioterap\u00e9utica per tractar malalties pulmonars humanes. La plataforma es basa en bacteris pulmonars atenuats capa\u00e7os d&#8217;administrar agents terap\u00e8utics en el pulm\u00f3 amb\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/pulmobiotics\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-02T14:14:50+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/pulmobiotics\/\",\"url\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/pulmobiotics\/\",\"name\":\"Pulmobiotics - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2020-04-08T08:31:16+00:00\",\"dateModified\":\"2021-09-02T14:14:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/pulmobiotics\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/pulmobiotics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/ca\/portoflio_invivo\/pulmobiotics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pulmobiotics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pulmobiotics - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/pulmobiotics\/","og_locale":"ca_ES","og_type":"article","og_title":"Pulmobiotics - Invivo Partners","og_description":"Pulmobiotics \u00e9s una empresa spin-off de el Centre de Regulaci\u00f3 Gen\u00f2mica (CRG). \u00c9s una empresa de ci\u00e8ncies de la vida en fase precl\u00ednica que utilitza la biologia sint\u00e8tica per desenvolupar una nova plataforma bioterap\u00e9utica per tractar malalties pulmonars humanes. La plataforma es basa en bacteris pulmonars atenuats capa\u00e7os d&#8217;administrar agents terap\u00e8utics en el pulm\u00f3 amb","og_url":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/pulmobiotics\/","og_site_name":"Invivo Partners","article_modified_time":"2021-09-02T14:14:50+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/pulmobiotics\/","url":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/pulmobiotics\/","name":"Pulmobiotics - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2020-04-08T08:31:16+00:00","dateModified":"2021-09-02T14:14:50+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/pulmobiotics\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/ca\/portoflio_invivo\/pulmobiotics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/ca\/portoflio_invivo\/pulmobiotics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/ca\/"},{"@type":"ListItem","position":2,"name":"Pulmobiotics"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/portoflio_invivo\/1227","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/portoflio_invivo"}],"about":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/types\/portoflio_invivo"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/media?parent=1227"}],"wp:term":[{"taxonomy":"tipo_portfolio","embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/tipo_portfolio?post=1227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}